As a new strategy was announced in yesterday's AGM, what's everyone's take on that, a separate thread might make it easier for new comers not to get lost in the sea of other topics.
I personally think the new strategy is great because: 1- Rewarding loyal holders will encourage more buying, holding to qualify as well as ease pressure on selling, we already have around 40% of total shares held by the board, rewarding loyal holders will bring the total shares not for sale in the short term up to 60%-70%
2- Listing in NASDAQ will now happen without issuing a single new share, every single new buyer from US will have to buy from open markets, this coupled with hiring a PR agency can only result in positive buying pressure.
3- We are expecting trials results soon with many positive sings that it is a good one, this is a phase 2 trial with easy to achieve end points, an pre-IND meeting is being scheduled with FDA to discuss the results, a patent is submitted, all these sings show that they are actually good results.
In 2021, SP returns were over 200%, with all these positive powers I see higher returns totally possible if you take an overall approach not focusing on daily SP movements.